Status:

COMPLETED

Reopening Schools Safely and Educating Youth Research Study (ROSSEY)

Lead Sponsor:

University of Washington

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Absenteeism

Eligibility:

All Genders

4+ years

Phase:

NA

Brief Summary

The study has three aims and involves a clustered randomized controlled trial (RCT) where K-5 schools will be the unit of randomization. Aim 1 involves a qualitative assessment of rural Latino communi...

Detailed Description

OBJECTIVE: Aim 1. Identify the rural Latino community's social, ethical, behavioral needs and resources for students to return to school and maintain onsite learning using qualitative assessments wit...

Eligibility Criteria

Inclusion

  • Participant attends or works in a participating school for at least 2 days/week.
  • Participant must be willing to comply with all study procedures, including weekly online check-ins and phone interviews.
  • Participant should have consistent and reliable Internet access, either by smart phone or computer.
  • Participant must be comfortable speaking English or Spanish.
  • Participant must be able to provide online informed consent and/or legal guardian assent.

Exclusion

  • Individuals unable to provide informed consent / assent, except in cases where the participant has an available legal authorized representative and/or parent
  • Individuals who are incarcerated
  • Individuals with conditions that may preclude or limit the participant's ability to comply with study procedures, according to the investigators
  • Children who are wards of the state and who have clinically-diagnosed dementia, terminal (\<5 years) illness, major psychiatric illness, severe hearing impairment, and inability to move, which will be assessed during the distribution of the study recruitment packets to families.

Key Trial Info

Start Date :

January 17 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

1095 Patients enrolled

Trial Details

Trial ID

NCT04859699

Start Date

January 17 2022

End Date

December 31 2024

Last Update

October 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington

Seattle, Washington, United States, 98109